Anti-allergic function of alpha-Tocopherol is mediated by suppression of PI3K-PKB activity in mast cells in mouse model of allergic rhinitis
Allergol. immunopatol
; 48(4): 395-400, jul.-ago. 2020. ilus, tab
Article
in En
| IBECS
| ID: ibc-199726
Responsible library:
ES1.1
Localization: BNCS
ABSTRACT
BACKGROUND: Alpha-Tocopherol (alpha -TCP), one major form of vitamin E, has been known as a treatment for airway allergic inflammation. However, the role and mechanism of alpha-TCP in treating allergic rhinitis remains unclear. OBJECTIVE: In this study we examined the inhibitory function of alpha-TCP in a mouse model of allergic rhinitis. METHODS: Allergic phenotype was examined by hematoxylin and eosin staining. Total IgE, OVA-specific IgE, OVA-specific IgG1 and OVA-specific IgG2a levels were examined by ELISA. mRNA expression was measured by qPCR, protein levels were examined by Western Blot. RESULTS: Histological analysis of the nasal membranes revealed that there was a significant reduction in inflammatory cells appearance in cross-sections in alpha-TCP treatment of Ovalbumin (OVA)-sensitized mice compared to OVA sensitized animals. In addition, eosinophils were significantly reduced in nasal mucosa of alpha-TCP treatment of OVA-sensitized mice compared to the OVA group. Lower total IgE, OVA-specific IgE, OVA-specific IgG1 and OVA-specific IgG2a levels were found in alpha-TCP treatment of OVA-sensitized mice compared to the OVA group. Furthermore, we found that the subepithelial distribution of tryptase positive mast cells was reduced in the alpha-TCP treatment of OVA-sensitized mice. More importantly, the PI3K-PKB pathway was suppressed by alpha-TCP in mast cells. CONCLUSIONS: Our results demonstrated that α-TCP-mediated suppression of PI3K-PKB activity in mast cells is a potential mechanism of anti-allergic function of alpha-TCP
RESUMEN
No disponible
Search on Google
Collection:
06-national
/
ES
Database:
IBECS
Main subject:
Alpha-Tocopherol
/
Rhinitis, Allergic
/
Antioxidants
Limits:
Animals
Language:
En
Journal:
Allergol. immunopatol
Year:
2020
Document type:
Article